Zepp Health Corporation reported a significant 46.2% year-over-year revenue growth for the second quarter of 2025, reaching $59.4 million, driven by the success of its Amazfit products. This marks the company’s first overall revenue growth since 2021, highlighting the effectiveness of its strategic focus on the Amazfit ecosystem. The company introduced new products, including the Amazfit Balance 2 and Helio Strap, and welcomed prominent athletes to its brand ambassador team, which contributed to increased brand recognition and sales. Despite a narrowed net loss, Zepp Health’s gross margin remained stable, and the company anticipates continued growth in the third quarter with projected revenues between $72.0 million and $76.0 million, representing a 70% to 79% year-over-year increase.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.